Skip to search formSkip to main contentSkip to account menu

Multikinase Inhibitor 4SC-203

Known as: 4SC-203 
A multikinase inhibitor with potential antineoplastic activity. Multikinase inhibitor 4SC-203 selectively inhibits FMS-related tyrosine kinase 3… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Chemotherapy is an important treatment for cancer patients, especially for those with unresectable lesions. Targeted therapy of… 
2015
2015
Over the past decade, several multikinase inhibitors have shown considerable effectiveness against metastatic radioiodine… 
2014
2014
E ruptive melanocytic nevi (EMN) have been described as the sudden-onset development of numerous melanocytic nevi in association… 
2011
2011
7565 Background: Sorafenib (S) is an oral multikinase inhibtor. The safety, antitumor activity, and pharmacokinetics of the… 
Review
2008
Review
2008
ZusammenfassungDie chronisch myeloische Leukämie ist eine Stammzellerkrankung, welche durch das BCR/ABL Onkoprotein…